- Home
- FDBC vs LRMR Comparison
FDBC vs LRMR Comparison
Compare FDBC & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDBC
- LRMR
- Stock Information
- Founded
- FDBC 1902
- LRMR N/A
- Country
- FDBC United States
- LRMR United States
- Employees
- FDBC N/A
- LRMR N/A
- Industry
- FDBC Major Banks
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- FDBC Finance
- LRMR Health Care
- Exchange
- FDBC Nasdaq
- LRMR Nasdaq
- Market Cap
- FDBC 238.0M
- LRMR 191.4M
- IPO Year
- FDBC N/A
- LRMR N/A
- Fundamental
- Price
- FDBC $48.59
- LRMR $3.09
- Analyst Decision
- FDBC
- LRMR Strong Buy
- Analyst Count
- FDBC 0
- LRMR 7
- Target Price
- FDBC N/A
- LRMR $17.86
- AVG Volume (30 Days)
- FDBC 9.6K
- LRMR 1.4M
- Earning Date
- FDBC 07-23-2025
- LRMR 08-06-2025
- Dividend Yield
- FDBC 3.29%
- LRMR N/A
- EPS Growth
- FDBC 32.34
- LRMR N/A
- EPS
- FDBC 3.75
- LRMR N/A
- Revenue
- FDBC $81,316,000.00
- LRMR N/A
- Revenue This Year
- FDBC N/A
- LRMR N/A
- Revenue Next Year
- FDBC N/A
- LRMR N/A
- P/E Ratio
- FDBC $12.96
- LRMR N/A
- Revenue Growth
- FDBC 15.07
- LRMR N/A
- 52 Week Low
- FDBC $37.00
- LRMR $1.61
- 52 Week High
- FDBC $61.21
- LRMR $11.20
- Technical
- Relative Strength Index (RSI)
- FDBC 71.22
- LRMR 62.04
- Support Level
- FDBC $43.55
- LRMR $2.81
- Resistance Level
- FDBC $49.43
- LRMR $3.33
- Average True Range (ATR)
- FDBC 1.25
- LRMR 0.30
- MACD
- FDBC 0.71
- LRMR 0.01
- Stochastic Oscillator
- FDBC 91.53
- LRMR 88.29
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.